← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (104)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 Study (15)Clinical trial (370)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications and studies (1543)

• Influence of Transcranial Direct Current Stimulation and Exercise on Fatigue and Quality of Life in Multiple Sclerosis. (2022/12/28) ♡
• The Dectin-1 Receptor Signaling Pathway Mediates the Remyelination Effect of Lentinan through Suppression of Neuroinflammation and Conversion of Microglia. (2022/12/28) ♡
• Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity. (2022/12/23) ♡
• Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis. (2022/12/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin D in Neurological Diseases. (2022/12/21) ♡
• Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score-matched study. (2022/12/19) ♡
• The role of oxidative stress in neurodegenerative diseases and potential antioxidant therapies. (2022/12/19) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures. (2022/12/16) ♡
• Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer. (2022/12/16) ♡
• Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies. (2022/12/14) ♡
• The Assessment of the Prevalence and Disability Severity of Musculoskeletal Pain in Patients With Multiple Sclerosis in Saudi Arabia. (2022/12/11) ♡
• Determinants of early working impairments in multiple sclerosis. (2022/12/09) ♡
• A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis. (2022/12/09) ♡
• miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis. (2022/12/09) ♡
• Emotional Recognition and Its Relation to Cognition, Mood and Fatigue in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis. (2022/12/07) ♡
• Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis. (2022/12/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lichen Sclerosus: A Current Landscape of Autoimmune and Genetic Interplay. (2022/12/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate. (2022/12/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Epigenetics in Neuroinflammatory-Driven Diseases. (2022/12/02) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence. (2022/12/02) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Density strips: visualisation of uncertainty in clinical data summaries and research findings. (2022/12/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study. (2022/12/01) ♡
• Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis. (2022/12/01) ♡
• Spatiotemporal gait changes in people with multiple sclerosis with different disease progression subtypes. (2022/12/01) ♡
• JCV seroconversion rate during the SARS COVID-19 pandemic. (2022/12/01) ♡
• OCT and VEP correlate to disability in secondary progressive multiple sclerosis. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of the Bruton tyrosine kinase pathway in multiple sclerosis. (2022/12/01) ♡
• A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis. (2022/11/30) ♡
• Irrespective of Plaque Activity, Multiple Sclerosis Brain Periplaques Exhibit Alterations of Myelin Genes and a TGF-Beta Signature. (2022/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Anti-MOG Positive Bilateral Optic Neuritis and Brainstem Encephalitis Secondary to COVID-19 Infection: A Case Report. (2022/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Pragmatic impairment in multiple sclerosis after worsening of clinical symptoms. (2022/11/24) ♡
• Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs. (2022/11/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies. (2022/11/22) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Measuring progression in Multiple Sclerosis: Progressing beyond the ordinary. (2022/11/22) ♡
• The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis. (2022/11/19) ♡
• Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study. (2022/11/17) ♡
• Impact of Siponimod on Enteric and Central Nervous System Pathology in Late-Stage Experimental Autoimmune Encephalomyelitis. (2022/11/17) ♡
• Integration of small RNAs from plasma and cerebrospinal fluid for classification of multiple sclerosis. (2022/11/17) ♡
• Premature Ventricular Contractions and Cardiomyopathy while on Ofatumumab for Treatment of Chronic Lymphocytic Leukaemia. (2022/11/14) ♡
• Shared decision-making in patients with multiple sclerosis. (2022/11/11) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD. (2022/11/07) ♡
• miR-181a-5p is a potential candidate epigenetic biomarker in multiple sclerosis. (2022/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mitochondrial Dysfunction and Neurodegenerative Disorders: Role of Nutritional Supplementation. (2022/10/20) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis. (2022/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Stem cell therapy for cuprizone model of multiple sclerosis focusing on the effectiveness of different injection methods and cell labeling. (2022/10/01) ♡
• Confounder-adjusted MRI-based predictors of multiple sclerosis disability. (2022/09/13) ♡
• Ocular manifestations of multiple sclerosis in patients from three countries: A Web-based survey. (2022/09/01) ♡
• Treatable Ataxias: How to Find the Needle in the Haystack? (2022/09/01) ♡
• Facilitators of and Barriers to Adherence to Dietary Interventions Perceived by Women With Multiple Sclerosis and Their Support Persons. (2022/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cognitive dysfunction and mortality in multiple sclerosis: Long-term retrospective review. (2022/08/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.